Efficacy and Safety of Levetiracetam in Children with Partial Seizures: An Open-label Trial

Purpose: To assess the efficacy and safety of levetiracetam (LEV) as adjunctive therapy in children with treatment‐resistant partial‐onset seizures. Methods: Children (aged 6–12 years) with treatment‐resistant partial‐onset seizures receiving one standard antiepileptic drug (AED) were eligible. Afte...

Full description

Saved in:

Bibliographic Details
Published in:	Epilepsia (Copenhagen) Vol. 43; no. 5; pp. 518 - 524
Main Authors:	Glauser, Tracy A., Pellock, John M., Bebin, E. Martina, Fountain, Nathan B., Ritter, Frank J., Jensen, Christof M., Shields, W. Donald
Format:	Journal Article
Language:	English
Published:	Boston, MA, USA Blackwell Science Inc 01.05.2002 Blackwell
Subjects:	Age Factors Age of Onset Anorexia - chemically induced Anticonvulsants - adverse effects Anticonvulsants - blood Anticonvulsants - therapeutic use Anticonvulsants. Antiepileptics. Antiparkinson agents Biological and medical sciences Child Children Drug Administration Schedule Drug Therapy, Combination Epilepsies, Partial - blood Epilepsies, Partial - drug therapy Epilepsy Female Headache - chemically induced Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy Humans Infection - chemically induced Keppra Levetiracetam Male Medical sciences Nervous system (semeiology, syndromes) Neurology Neuropharmacology Partial seizures Pharmacology. Drug treatments Piracetam - adverse effects Piracetam - analogs & derivatives Piracetam - blood Piracetam - therapeutic use Sleep Wake Disorders - chemically induced Treatment Outcome Human Nervous system diseases Chemotherapy Partial Treatment efficiency Epilepsy Central nervous system disease Tolerance Anticonvulsant Child Cerebral disorder Levetiracetam
ISSN:	0013-9580, 1528-1167
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!